TOPLINE:

A new study revealed racial and ethnic disparities in access to opioid use disorder (OUD) treatment after emergency department (ED) visits, with Black and Hispanic individuals facing greater barriers than White individuals.

METHODOLOGY:

Researchers conducted a qualitative study between 2023 and 2024, involving in-depth telephone interviews with 57 adults with moderate-to-severe OUD who had previously participated in the ED-Innovation trial. The trial compared the effectiveness of sublingual buprenorphine vs 7-day injectable extended-release buprenorphine across 29 ED sites for formal addiction treatment engagement at day 7.

Participants had a mean age of 41.7 years, and 35.1% were women. Of these, 35.1% were Black, 29.8% were Hispanic, and 35.1% were White.

The telephonic int

See Full Page